These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30323818)

  • 21. The source of Mycobacterium tuberculosis-specific IFN-γ production in peripheral blood mononuclear cells of TB patients.
    Wang F; Mao L; Hou H; Wu S; Huang M; Yin B; Huang J; Zhu Q; Pan Y; Sun Z
    Int Immunopharmacol; 2016 Mar; 32():39-45. PubMed ID: 26796515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active Tuberculosis Is Associated with Depletion of HIV-Specific CD4 and CD8 T Cells in People with HIV.
    Khayumbi J; Sasser LE; McLaughlin TA; Muchiri B; Ongalo J; Tonui J; Ouma SG; Campbell A; Odhiambo FH; Kiprotich C; Gandhi NR; Day CL
    AIDS Res Hum Retroviruses; 2024 Jul; 40(7):417-427. PubMed ID: 38366732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of Circulating CD4
    Ferrian S; Ross M; Conradie F; Vally Omar S; Ismail N; Little F; Kaplan G; Fallows D; Gray CM
    Front Immunol; 2018; 9():2438. PubMed ID: 30410488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recruitment of Mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis.
    Nemeth J; Winkler HM; Zwick RH; Rumetshofer R; Schenk P; Burghuber OC; Graninger W; Ramharter M; Winkler S
    J Intern Med; 2009 Jan; 265(1):163-8. PubMed ID: 18793244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Petruccioli E; Petrone L; Chiacchio T; Farroni C; Cuzzi G; Navarra A; Vanini V; Massafra U; Lo Pizzo M; Guggino G; Caccamo N; Cantini F; Palmieri F; Goletti D
    Front Immunol; 2021; 12():716857. PubMed ID: 34447382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis.
    Petruccioli E; Petrone L; Vanini V; Cuzzi G; Navarra A; Gualano G; Palmieri F; Girardi E; Goletti D
    J Infect; 2015 Nov; 71(5):526-33. PubMed ID: 26253021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
    Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
    Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
    Gao Y; Zhang S; Ou Q; Shen L; Wang S; Wu J; Weng X; Chen ZW; Zhang W; Shao L
    Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
    Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M
    Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test.
    Silva BC; Grassi MF; Coutinho R; Mascarenhas RE; Olavarria VN; Coutinho-Borgo A; Kalil J; Cunha Neto E; Fonseca SG
    Mem Inst Oswaldo Cruz; 2014 Dec; 109(8):999-1004. PubMed ID: 25494469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis.
    Marín ND; París SC; Rojas M; García LF
    Clin Vaccine Immunol; 2012 Oct; 19(10):1667-76. PubMed ID: 22914361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of HLA-DR*08032/E7 and HLA-DR*0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors.
    Li Y; Zhu Y; Zhou L; Fang Y; Huang L; Ren L; Peng Y; Li Y; Yang F; Xie D; Tang W; Zhang N; Zhong Q; Lai X
    Immunobiology; 2011 Aug; 216(8):947-60. PubMed ID: 21281984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD38 Expression by Antigen-Specific CD4 T Cells Is Significantly Restored 5 Months After Treatment Initiation Independently of Sputum Bacterial Load at the Time of Tuberculosis Diagnosis.
    Hiza H; Hella J; Arbués A; Sasamalo M; Misana V; Fellay J; Gagneux S; Reither K; Portevin D
    Front Med (Lausanne); 2022; 9():821776. PubMed ID: 35492319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis.
    Axelsson-Robertson R; Ju JH; Kim HY; Zumla A; Maeurer M
    Int J Infect Dis; 2015 Mar; 32():13-22. PubMed ID: 25809750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active tuberculosis is characterized by an antigen specific and strictly localized expansion of effector T cells at the site of infection.
    Nemeth J; Rumetshofer R; Winkler HM; Burghuber OC; Müller C; Winkler S
    Eur J Immunol; 2012 Nov; 42(11):2844-50. PubMed ID: 22821397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis.
    Xu F; Zhang H; Si X; Chen J; Chen Y; Cui X; Qin Y
    BMC Immunol; 2021 Jun; 22(1):41. PubMed ID: 34176483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
    Dintwe OB; Day CL; Smit E; Nemes E; Gray C; Tameris M; McShane H; Mahomed H; Hanekom WA; Scriba TJ
    Eur J Immunol; 2013 Sep; 43(9):2409-20. PubMed ID: 23737382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD137 is a Useful Marker for Identifying CD4
    Yan ZH; Zheng XF; Yi L; Wang J; Wang XJ; Wei PJ; Jia HY; Zhou LJ; Zhao YL; Zhang HT
    Scand J Immunol; 2017 May; 85(5):372-380. PubMed ID: 28218958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+ regulatory T cells and CD4+ activated T cells in new active and relapse tuberculosis.
    Ndishimye P; Zakham F; Musanabaganwa C; Migambi P; Mihai C; Soritau O; El Mzibri M; Pop CM; Mutesa L
    Cell Mol Biol (Noisy-le-grand); 2019 Dec; 65(8):18-22. PubMed ID: 32133974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.